Please enable JavaScript to continue using this application.

Compare $CAI vs $CYTK | Chartloom

Compare

$CAI vs $CYTK

Caris Life Sciences Inc · Cytokinetics Inc

CAI

Caris Life Sciences Inc

CYTK

Cytokinetics Inc

Compare $CAI vs $CYTK

Comparing Caris Life Sciences Inc and Cytokinetics Inc

CAICaris Life Sciences Inc

CYTKCytokinetics Inc

CAICaris Life Sciences Inc

Market cap

$8.40B

P/E (TTM)

79.91x

Forward P/E (NTM)

101.64x

Forward P/S (NTM)

7.48x

Rev growth (TTM)

24.4%

YTD performance

10.1%

52W performance

-9.9%

FCF yield

1.5%

CYTKCytokinetics Inc

Market cap

$8.53B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

33.61x

Rev growth (TTM)

-21.1%

YTD performance

1.9%

52W performance

3.4%

FCF yield

-6.8%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

CAI

CYTK

Detailed metrics comparison

CAI

Caris Life Sciences Inc

CYTK

Cytokinetics Inc

Market Cap

CAI$8.40B

CYTK$8.53B

Enterprise Value

CAI$8.10B

CYTK$9.42B

Price

CAI$29.70

CYTK$62.91

P/E Ratio

CAI79.91x

CYTKN/A

P/S Ratio

CAI8.48x

CYTK126.04x

EV/Sales

CAI8.18x

CYTK139.22x

EV/EBITDA

CAI45.95x

CYTK1,193.30x

P/B Ratio

CAI13.52x

CYTK83.67x

P/FCF Ratio

CAI67.73x

CYTKN/A

EV/FCF

CAI65.33x

CYTK-16.22x

PEG Ratio

CAIN/A

CYTKN/A

Forward P/E (NTM)

CAI101.64x

CYTKN/A

Forward P/S (NTM)

CAI7.48x

CYTK33.61x

Revenue (TTM)

CAI$990M

CYTK$68M

Revenue Growth (YoY)

CAI24.4%

CYTK-21.1%

Forward Rev Growth

CAI18.2%

CYTK183.7%

Gross Margin (TTM)

CAI69.7%

CYTK58.9%

Operating Margin (TTM)

CAI12.7%

CYTK0.0%

EBITDA Margin (TTM)

CAI17.6%

CYTK-1027.6%

Net Margin (TTM)

CAI10.6%

CYTK-1321.1%

FCF Margin (TTM)

CAI12.5%

CYTK-858.2%

Net Income (TTM)

CAI$105M

CYTK$-894M

FCF (TTM)

CAI$124M

CYTK$-581M

EPS (TTM)

CAI$0.37

CYTK-$6.77

ROE (TTM)

CAI18.8%

CYTK-13119.0%

ROA (TTM)

CAI9.3%

CYTK-5902.0%

ROIC (TTM)

CAI11.2%

CYTK-1872.0%

Cash

CAI$691M

CYTK$255M

Debt

CAI$393M

CYTK$1.15B

Net Cash/Debt

CAI$298M

CYTK$-892M

Current Ratio (TTM)

CAI5.53x

CYTK6.66x

Quick Ratio (TTM)

CAI4.78x

CYTK6.56x

Debt/Equity (TTM)

CAI0.66x

CYTK6.01x

Debt/Assets (TTM)

CAI0.0%

CYTK0.0%

Interest Coverage (TTM)

CAIN/A

CYTKN/A

Net Debt/EBITDA (TTM)

CAI0.00x

CYTK0.00x

Beta

CAI0.40

CYTK0.42

52W Performance

CAI-9.9%

CYTK3.4%

YTD Performance

CAI10.1%

CYTK1.9%

% from 52W High

CAI-11.7%

CYTK-28.8%

% from 52W Low

CAI109.3%

CYTK15.9%

Asset Turnover (TTM)

CAI0.88x

CYTK0.04x

FCF Yield (TTM)

CAI1.5%

CYTK-6.8%

Earnings Yield (TTM)

CAI1.3%

CYTK-10.5%

Dividend Yield (TTM)

CAIN/A

CYTKN/A

Rule of 40

CAI37.0

CYTK-879.2

EV/GP/RG

CAI0.86

CYTK0.73

Ticker research

View CAI research View CYTK research

Metric	CAI Caris Life Sciences Inc	CYTK Cytokinetics Inc
Market & Valuation
Market Cap	$8.40B	$8.53B
Enterprise Value	$8.10B	$9.42B
Price	$29.70	$62.91
P/E Ratio	79.91x	N/A
P/S Ratio	8.48x	126.04x
EV/Sales	8.18x	139.22x
EV/EBITDA	45.95x	1,193.30x
P/B Ratio	13.52x	83.67x
P/FCF Ratio	67.73x	N/A
EV/FCF	65.33x	-16.22x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	101.64x	N/A
Forward P/S (NTM)	7.48x	33.61x
Revenue & Growth
Revenue (TTM)	$990M	$68M
Revenue Growth (YoY)	24.4%	-21.1%
Forward Rev Growth	18.2%	183.7%
Profitability
Gross Margin (TTM)	69.7%	58.9%
Operating Margin (TTM)	12.7%	0.0%
EBITDA Margin (TTM)	17.6%	-1027.6%
Net Margin (TTM)	10.6%	-1321.1%
FCF Margin (TTM)	12.5%	-858.2%
Net Income (TTM)	$105M	$-894M
FCF (TTM)	$124M	$-581M
EPS (TTM)	$0.37	-$6.77
ROE (TTM)	18.8%	-13119.0%
ROA (TTM)	9.3%	-5902.0%
ROIC (TTM)	11.2%	-1872.0%
Financial Health
Cash	$691M	$255M
Debt	$393M	$1.15B
Net Cash/Debt	$298M	$-892M
Current Ratio (TTM)	5.53x	6.66x
Quick Ratio (TTM)	4.78x	6.56x
Debt/Equity (TTM)	0.66x	6.01x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.40	0.42
52W Performance	-9.9%	3.4%
YTD Performance	10.1%	1.9%
% from 52W High	-11.7%	-28.8%
% from 52W Low	109.3%	15.9%
Efficiency & Yields
Asset Turnover (TTM)	0.88x	0.04x
FCF Yield (TTM)	1.5%	-6.8%
Earnings Yield (TTM)	1.3%	-10.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	37.0	-879.2
EV/GP/RG	0.86	0.73
Ticker research	View CAI research	View CYTK research

Valuation

P/E Ratio

CAI

79.91x

P/S Ratio

CAI

8.48x

CYTK

126.04x

EV/FCF

CYTK

-16.22x

CAI

65.33x

Growth & revenue

Revenue Growth TTM

CAI

24.4%

CYTK

-21.1%

Forward Revenue Growth

CYTK

183.7%

CAI

18.2%

Profitability & performance

Gross Margin

CAI

69.7%

CYTK

58.9%

ROE

CAI

18.8%

CYTK

-13119.0%

FCF Yield %

CAI

1.5%

CYTK

-6.8%

52-Week Performance

CYTK

3.4%

CAI

-9.9%

Detailed metrics comparison

CAI

Caris Life Sciences Inc

CYTK

Cytokinetics Inc

Market Cap

CAI$8.40B

CYTK$8.53B

Enterprise Value

CAI$8.10B

CYTK$9.42B

Price

CAI$29.70

CYTK$62.91

P/E Ratio

CAI79.91x

CYTKN/A

P/S Ratio

CAI8.48x

CYTK126.04x

EV/Sales

CAI8.18x

CYTK139.22x

EV/EBITDA

CAI45.95x

CYTK1,193.30x

P/B Ratio

CAI13.52x

CYTK83.67x

P/FCF Ratio

CAI67.73x

CYTKN/A

EV/FCF

CAI65.33x

CYTK-16.22x

PEG Ratio

CAIN/A

CYTKN/A

Forward P/E (NTM)

CAI101.64x

CYTKN/A

Forward P/S (NTM)

CAI7.48x

CYTK33.61x

Revenue (TTM)

CAI$990M

CYTK$68M

Revenue Growth (YoY)

CAI24.4%

CYTK-21.1%

Forward Rev Growth

CAI18.2%

CYTK183.7%

Gross Margin (TTM)

CAI69.7%

CYTK58.9%

Operating Margin (TTM)

CAI12.7%

CYTK0.0%

EBITDA Margin (TTM)

CAI17.6%

CYTK-1027.6%

Net Margin (TTM)

CAI10.6%

CYTK-1321.1%

FCF Margin (TTM)

CAI12.5%

CYTK-858.2%

Net Income (TTM)

CAI$105M

CYTK$-894M

FCF (TTM)

CAI$124M

CYTK$-581M

EPS (TTM)

CAI$0.37

CYTK-$6.77

ROE (TTM)

CAI18.8%

CYTK-13119.0%

ROA (TTM)

CAI9.3%

CYTK-5902.0%

ROIC (TTM)

CAI11.2%

CYTK-1872.0%

Cash

CAI$691M

CYTK$255M

Debt

CAI$393M

CYTK$1.15B

Net Cash/Debt

CAI$298M

CYTK$-892M

Current Ratio (TTM)

CAI5.53x

CYTK6.66x

Quick Ratio (TTM)

CAI4.78x

CYTK6.56x

Debt/Equity (TTM)

CAI0.66x

CYTK6.01x

Debt/Assets (TTM)

CAI0.0%

CYTK0.0%

Interest Coverage (TTM)

CAIN/A

CYTKN/A

Net Debt/EBITDA (TTM)

CAI0.00x

CYTK0.00x

Beta

CAI0.40

CYTK0.42

52W Performance

CAI-9.9%

CYTK3.4%

YTD Performance

CAI10.1%

CYTK1.9%

% from 52W High

CAI-11.7%

CYTK-28.8%

% from 52W Low

CAI109.3%

CYTK15.9%

Asset Turnover (TTM)

CAI0.88x

CYTK0.04x

FCF Yield (TTM)

CAI1.5%

CYTK-6.8%

Earnings Yield (TTM)

CAI1.3%

CYTK-10.5%

Dividend Yield (TTM)

CAIN/A

CYTKN/A

Rule of 40

CAI37.0

CYTK-879.2

EV/GP/RG

CAI0.86

CYTK0.73

Ticker research

View CAI research View CYTK research

Metric	CAI Caris Life Sciences Inc	CYTK Cytokinetics Inc
Market & Valuation
Market Cap	$8.40B	$8.53B
Enterprise Value	$8.10B	$9.42B
Price	$29.70	$62.91
P/E Ratio	79.91x	N/A
P/S Ratio	8.48x	126.04x
EV/Sales	8.18x	139.22x
EV/EBITDA	45.95x	1,193.30x
P/B Ratio	13.52x	83.67x
P/FCF Ratio	67.73x	N/A
EV/FCF	65.33x	-16.22x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	101.64x	N/A
Forward P/S (NTM)	7.48x	33.61x
Revenue & Growth
Revenue (TTM)	$990M	$68M
Revenue Growth (YoY)	24.4%	-21.1%
Forward Rev Growth	18.2%	183.7%
Profitability
Gross Margin (TTM)	69.7%	58.9%
Operating Margin (TTM)	12.7%	0.0%
EBITDA Margin (TTM)	17.6%	-1027.6%
Net Margin (TTM)	10.6%	-1321.1%
FCF Margin (TTM)	12.5%	-858.2%
Net Income (TTM)	$105M	$-894M
FCF (TTM)	$124M	$-581M
EPS (TTM)	$0.37	-$6.77
ROE (TTM)	18.8%	-13119.0%
ROA (TTM)	9.3%	-5902.0%
ROIC (TTM)	11.2%	-1872.0%
Financial Health
Cash	$691M	$255M
Debt	$393M	$1.15B
Net Cash/Debt	$298M	$-892M
Current Ratio (TTM)	5.53x	6.66x
Quick Ratio (TTM)	4.78x	6.56x
Debt/Equity (TTM)	0.66x	6.01x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.40	0.42
52W Performance	-9.9%	3.4%
YTD Performance	10.1%	1.9%
% from 52W High	-11.7%	-28.8%
% from 52W Low	109.3%	15.9%
Efficiency & Yields
Asset Turnover (TTM)	0.88x	0.04x
FCF Yield (TTM)	1.5%	-6.8%
Earnings Yield (TTM)	1.3%	-10.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	37.0	-879.2
EV/GP/RG	0.86	0.73
Ticker research	View CAI research	View CYTK research